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IN HUMANS,1 RATS,2 AND MICE,3 NEWBORNS CYCLE 
RAPIDLY BETWEEN SLEEP AND WAKEFULNESS. ONE OF 
THE DEFINING FEATURES OF EARLY SLEEP-WAKE devel-
opment is the consolidation of individual sleep and wake bouts, 
as well as the circadian entrainment of the sleep-wake rhythm.4 
In addition, analyses of the statistical distributions of sleep and 
wake bouts have indicated dramatic changes in the dynamics of 
sleep-wake activity. Specifically, whereas sleep bout durations 
distribute exponentially in infant5 and adult6,7 mammals, wake 
bout durations distribute exponentially during the early postnatal 
period and then transition to a power-law distribution that, in rats, 
occurs around the time of eye opening at postnatal day (P)15.8
Several factors may account for the developmental transition 
from exponential to power-law wake behavior. For example, 
because the transition occurs around the time of eye opening, 
it is possible that some aspect of visual stimulation is involved. 
However, bilateral enucleation at P3 or P11 does not prevent 
the normal emergence of power-law wake behavior.4 Alterna-
tively, it is possible that orexinergic neurons, localized in the 
lateral hypothalamic nucleus (LHA) and dorsomedial hypotha-
lamic nucleus (DMH), contribute to the emergence of power-
law wake behavior by activating wake-active monoaminergic 
and cholinergic neurons in the brainstem.9-11 However, power-
law wake behavior emerges in orexin knockout mice just as it 
does in wild-types.3 A third possibility, examined here, is that 
functional changes in locus coeruleus (LC) activity contribute 
to the development of power-law wake behavior.
The LC is a major source of noradrenaline (NA) in the cen-
tral nervous system and plays an important role in arousal. In 
adult rats, activity levels of LC neurons increase during wake-
fulness, decrease their firing rate during quiet sleep, and are 
nearly silent during active sleep12,13; state-related changes in LC 
activity are detectable as early as P8 in rats.14 Increased dis-
charge rates of LC neurons are associated with spontaneous or 
sensory-evoked interruptions of sleep.12,15 Finally, stimulation 
of LC activity promotes wakefulness,16,17 whereas inhibition of 
LC activity promotes sleep.18
To test the hypothesis that the LC contributes to the develop-
mental emergence of power-law wake behavior, we administered 
N-(2-choloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4), a 
neurotoxin that selectively destroys noradrenergic LC terminals 
in infant19 and adult20-23 rats. In the present study, DSP-4 was ad-
ministered to P7 rats and we examined their sleep-wake behavior 
2 weeks later, at P21. We predicted that interfering with LC func-
tion in early infancy would prevent or dampen the developmental 
transition from exponential to power-law wake behavior.
Methods
All experiments were performed in accordance with Na-
tional Institutes of Health guidelines for the care of animals in 
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research and were approved by the Institutional Animal Care 
and Use Committee of the University of Iowa. All efforts were 
made to minimize the number of animals used.
subjects
Thirty-two Sprague-Dawley rats from 8 litters were used. 
Males and females were equally represented and littermates 
were always assigned to different experimental groups. Litters 
were culled to 8 pups within 3 days of birth (day of birth = P0). 
Mothers and their litters were housed and raised in standard 
laboratory cages (48 × 20 × 26 cm) in the animal colony at the 
University of Iowa. Food and water were available ad libitum. 
All animals were maintained on a 12-h light-dark schedule with 
lights on at 07:00.
dsp-4 treatment
At P7, 4 same-sex litter mates were chosen as experimental 
subjects. Two of these pups were injected subcutaneously with 
50 mg/kg of DSP-4 (Sigma, St. Louis, MO), and 2 control pups 
were injected with saline. Pups were then tattooed and placed 
back in the litter for testing 2 weeks later. The same procedure 
was used for the remaining 7 litters.
surgery
On the day of testing at P21-22 (hereafter referred to as P21), 
2 same-sex littermates, 1 previously injected with DSP-4 and 1 
with saline, were implanted with nuchal EMG electrodes. Un-
der isoflurane anesthesia, 2 bipolar stainless steel electrodes (50 
µm diameter, California Fine Wire, Grover Beach, CA) were 
inserted bilaterally into the nuchal muscles and secured with 
flexible collodion.24 After surgery, pups recovered in a humidi-
fied test chamber maintained at thermoneutrality. All surgeries 
took place at least 2 h before testing. For testing at night, sur-
gery was performed under dim red light illumination, with care 
being taken to ensure that infants were not exposed to white 
light. After surgery, each pup was transferred to an individual 
test chamber maintained at thermoneutrality (i.e., 32°C) where 
it recovered and acclimated for at least 2 h before testing.
test procedure
DSP-4 and saline control subjects were tested simultaneously 
but separately in two electrically shielded double-walled glass 
chambers (height, 18 cm; i.d., 12 cm). Air temperature inside 
each chamber was maintained at thermoneutrality by regulating 
the temperature of the water that circulated through the walls 
of the chamber. Compressed, humidified air passed through the 
sealed chamber at the rate of 300 mL/min. A round platform 
constructed of polyethylene mesh was fitted inside each cham-
ber, which allowed the pup to move freely on the platform’s 
surface.
The nuchal electrodes were connected to differential am-
plifiers (A-M systems, Carlsborg, WA) and their signals were 
amplified (×10 k) and filtered (300–5000 Hz). EMG data were 
acquired (1000 samples/s) and stored using a data acquisition 
system (Biopac Systems, Santa Barbara, CA).
During the day, data were acquired from 11:00 to 16:00. At 
night, the 2 remaining same-sex littermates were implanted 
with EMG electrodes (again, under red light illumination) and 
tested identically to those during the day, with data being ac-
quired from 23:00 to 04:00. The order of daytime and nighttime 
tests was counterbalanced across litters.
hpLc analysis of noradrenaline (na), dopamine (da), and 
serotonin (5-ht) concentrations
No more than 2 days after testing, each pup was anesthetized 
with isoflurane and decapitated. The brain was removed rapidly 
and placed on ice. The cerebral cortex was quickly dissected 
out, placed in 15 mL Sarstedt polypropylene tubes, and frozen 
in liquid nitrogen. Samples were stored at −80˚C until homog-
enization. The cerebral cortex of each rat was homogenized in 
0.1 Normal (N) perchloric acid. Homogenate was centrifuged 
at 17,300 g for 10 min at 4°C. The clear supernatant was filtered 
through a 0.22 µm Millex-GP filter unit (Millipore, Bedford, 
MA) and analyzed for levels of NA. Analysis was performed 
using a Waters 2690 HPLC (Milford, MA) equipped with an 
ESA Coulochem III (Chemford, MA) with E1 and E2 potentials 
set to -150 mV and 200 mV, respectively. Eight µL of sample 
diluted 1:4 with water were injected into a Synergi Hydro 4 
µm reversed phase column (Phenomenex, Torrance, CA) with a 
mobile phase containing 75 mM phosphoric acid, 25 mM citric 
acid, 1.8 mM sodium dodecyl sulfate, and 2% acetonitrile ad-
justed to pH 3.0.
A follow-up experiment was performed using 12 additional 
subjects from 6 litters. From each litter, 2 P7 littermates were 
injected with DSP-4 or saline as described earlier. At P21, the 
brain was removed, placed on ice, and the cortex was dissected 
out for analysis. In addition, the remaining brain tissue (includ-
ing medulla, midbrain, and diencephalon, minus the cerebel-
lum) was also saved. These cortical and non-cortical samples 
were prepared for HPLC analysis of NA, DA, and 5-HT con-
centrations. (These animals were not tested for sleep and wake-
fulness.) Samples were analyzed using an Agilent 1100 HPLC 
system (Santa Clara, CA) and an ESA Coulochem III elec-
trochemical detector (settings as previously described). Sepa-
ration was achieved by injecting 20 µL of undiluted sample 
onto a Thermo Aquasil C18 5 µm 150 × 2.1 mm column. DA 
and 5-HT were analyzed by an isocratic method using mobile 
phase containing 0.1% trifluoroacetic acid (TFA), 50 mM citric 
acid, 1% methanol, and 1% acetonitrile adjusted to pH 3.0. NA 
analysis was carried out using a gradient program; the aqueous 
phase contained 0.2% trifluoroacetic acid, 50 mM citric acid, 
and 2 mM sodium heptane sulfonate pH 3.0, and the organic 
phase contained acetonitrile 3% to 18% (3% at 0–8 minutes, 
linearly increasing to 18% by 19 minutes, and returning to 3% 
at 20 minutes).
data analysis
For all subjects, EMG data were analyzed off-line using Ac-
qKnowledge software (Biopac Systems, Santa Barbara, CA). 
The EMG signal was integrated and full-wave rectified, and 
then dichotomized into periods of high muscle tone and atonia 
(or wakefulness and sleep, respectively), as described earlier.2 
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An experienced individual blind to experimental condition 
scored the data. It should be stressed that EMG measures alone 
allow for accurate measurement of sleep and wake durations 
in infant rats before, during, and after the emergence of delta 
activity.25 Moreover, the statistical structures of sleep and wake 
bouts derived from EMG measures at P21 in rats8 and mice3 
resemble those derived in adults using additional electrographic 
measures.7
Sleep and wake bout durations were imported into Statview 
5.0 (SAS Institute, Cary, NC) for analysis. Mean and median 
bout durations were determined for each subject and mean val-
ues were calculated across subjects. Mean percentage of time 
awake was calculated by dividing the mean wake bout duration 
by the sum of the mean sleep and wake bout durations, and 
multiplying by 100. The mean number of sleep-wake cycles 
per hour was also calculated. Two-factor analysis of variance 
(ANOVA) was used to test for differences across groups (i.e., 
DSP-4 vs. saline control) and test times (i.e., day vs. night).
NA, DA, and 5-HT concentrations were expressed as ng/mL 
tissue homogenate and reported as percentage change in DSP-4 
subjects in relation to paired saline controls. Paired t tests were 
used to test group differences.
As described elsewhere,8 log-survivor distributions of sleep 
and wake bouts were produced from individual and pooled data. 
For each subject, least-squares estimates (r2) were calculated to 
assess the degree of fit to exponential and power-law distribu-
tions. Two-factor ANOVAs, performed separately for the day 
and night, were used to test for differences across group (i.e., 
DSP-4 vs. saline control) and distribution (i.e., power-law vs. 
exponential). Paired t tests were used for planned comparisons 
to assess within-group differences in r2.
For these tests, α was set at 0.05. Means are presented with 
their standard errors.
We used a second analytic technique to test whether bout 
duration data provided more evidence for a power-law or ex-
ponential model. Specifically, using pooled data, log-likelihood 
functions were calculated and maximized for each model.26-28 
The comparison was quantified by calculating the Akaike 
weights, wi (i = 1,2), for each model: wi = exp(-∆i/2)/(exp(-∆1/2) 
+ exp(-∆2/2)). Here, ∆i is a measure of each model relative to 
the better model; ∆i = 0 for the model with larger log-likelihood 
value. For the other model, ∆i > 0 is calculated as the difference 
of Akaike Information Criterion (AIC) values, AICi = −2(log-
likelihoodi) +2ki, where ki is the number of parameters in model 
i. (Note that the sum of the Akaike weights equals 1). The Akai-
ke weight for a model estimates the probability that the model 
is the better of the 2 candidate models.26,29 The Akaike weights 
are useful for model comparison. They give the probability of a 
certain model being a better fit among all the chosen candidate 
models. Therefore, the model with a weight of 1 is a better fit 
than the model with a weight of 0. It should be emphasized, 
however, that this criterion cannot tell us if the best-fit model 
is indeed a good fit. For goodness of fit, we use the more tradi-
tional approach.
resuLts
Table 1 shows that mean sleep bout durations were not 
significantly affected by DSP-4 treatment during the day or 
night (group: F1,28 = 0.7; test time: F1,28 = 1.5; group × time 
interaction: F1,28 = 0.0); median sleep bout durations were sig-
nificantly longer during the day (F1,28 = 6.9, P < 0.05); there 
was no main effect of group (F1,28 = 3.2) and no group × time 
interaction (F1,28 = 0.2). Both mean and median wake bout du-
rations were significantly longer in DSP-4 subjects (F1,28s > 
7.3, P < 0.05); there were no main effects of time (F1,28s < 3.6) 
and no group × time interactions (F1,28s < 1.0). Similarly, mean 
percentage time awake was significantly longer for DSP-4 
subjects than saline controls (F1,28 = 11.8, P < 0.005), and was 
significantly greater at night than during the day (F1,28 = 7.0, 
P < 0.05); the interaction was not significant (F1,28 = 0.0). Fi-
nally, the number of sleep-wake cycles per hour was not af-
fected by DSP-4 treatment (group: F1,28 = 0.2; time: F1,28 = 0.0; 
interaction: F1,28 = 0.1).
Figure 1 presents pooled log-survivor distributions for P21 
subjects treated at P7 with DSP-4 or saline. Sleep bout dura-
tions for both the DSP-4 and saline control P21 subjects during 
the day and night fall along a straight line, indicative of an ex-
ponential distribution (Fig. 1A). As predicted, wake bout dura-
tions for DSP-4 subjects more closely followed an exponential 
distribution during the day and night (Fig. 1B); in contrast, the 
wake bout durations for the saline control subjects followed a 
power-law distribution.
As shown in Figure 2A, sleep bout durations were always 
better fit by an exponential than a power-law distribution. ANO-
VAs performed separately for the day and night revealed signif-
icant main effects of distribution (F1,28s > 139.5, Ps < 0.0001), 
but there were no main effects of group (F1,28s < 2.1). Also, the 
group × distribution interaction was significant at night (F1,28 = 
6.8, P < 0.05) but not during the day (F1,28 = 2.6).
Table 1—Sleep and Wake Bout Durations, Percentage of Time Awake, and Number of Sleep-Wake Cycles per Hour in P21 Rats Treated on 
P7 with DSP-4 or Saline
Group Sleep bout duration (s) Wake bout duration (s) Mean % of Mean no. of
  Mean Median Mean Median time awake sleep-wake
DSP-4      cycles per h
 Day 82.5 (8.2) 53.6 (7.4)a 40.9 (5.6)b 17.3 (2.7)b 33.3 (4.3)a,b 30.4 (2.4)
 Night 73.4 (8.6)  32.9 (6.2)  55.2 (10.7)b 25.5 (7.2)b 41.4 (4.1)b 31.6 (4.5)
Saline      
 Day 89.2 (7.0) 62.3 (6.9)a 25.4 (3.2) 6.5 (0.7) 21.9 (1.6)a 33.2 (3.8)
 Night 79.8 (6.0) 48.0 (6.3) 35.7 (3.3) 7.1 (0.5) 30.8 (1.9) 32.1 (2.3)
Standard Errors are in Parentheses. asignificant main effect of test time (i.e., day vs. night). bsignificant main effect of group (i.e., DSP-4 vs. saline)
Power-Law Wake Behavior and the Locus Coeruleus—Gall et al
SLEEP, Vol. 32, No. 7, 2009 923
Figure 2B, that DSP-4 treatment suppresses the expression of 
power-law wake behavior at P21.
A follow-up analysis of individual data indicated that 2 DSP-
4 subjects exhibited differences from the pooled results. Spe-
cifically, one DSP-4 subject’s wake bout durations were better 
fit by a power-law model (Akaike weight equal to 1), and the 
other DSP-4 subject’s wake bout durations distributed poorly to 
both exponential and power-law models.
Finally, to provide additional information regarding the ef-
fect of DSP-4 treatment on NA, DA, and 5-HT concentrations 
in cortical and non-cortical tissue, 12 additional subjects from 6 
litters were tested identically to the initial set of subjects (with 
the exception that sleep-wake activity was not monitored). As 
shown in Table 2, animals treated with DSP-4 at P7 exhibited 
significant reductions at P21 in both cortical (t21 = 19.2, P < 
0.0001) and non-cortical (t5 = 9.5, P < 0.0005) NA concentra-
tion in relation to saline controls. Importantly, and as expected,19 
DSP-4 subjects did not exhibit significant changes in cortical 
or non-cortical DA or 5-HT concentration in relation to saline 
controls (t5s > 0.1, NS).
Figure 2B shows, as expected,8 that wake bout durations for 
saline control subjects during the day and night were better fit 
by a power-law distribution. In contrast, for DSP-4 subjects at 
night, the better fit was to an exponential distribution. For DSP-
4 subjects during the day, the fit to a power-law distribution was 
clearly reduced, although the fit to an exponential distribution 
was not increased. ANOVAs revealed a significant main effect 
of distribution during the day (F1,28 = 16.4, P < 0.0005) but not 
at night (F1,28 = 1.4). There were no main effects of group dur-
ing the day or night (F1,28s < 3.2), but the group × distribution 
interactions were significant (F1,28s > 11.6, Ps < 0.005).
As expected, analyses of pooled and individual Akaike 
weights indicated that sleep bout durations were better fit by 
an exponential model in both saline control and DSP-4 subjects 
during the day and night (Akaike weights equal to 1). Also as 
expected, wake bout durations for saline control subjects were 
better fit by a power-law model during both the day and night 
(Akaike weights equal to 1). In contrast, wake bout durations 
for DSP-4 subjects were better fit by an exponential model dur-
ing both the day and night (Akaike weights equal to 1), thus 
providing even stronger support for the finding, presented in 
Table 2—Mean Percentage Change in Cortical and Non-Cortical 
Noradrenaline (NA), Dopamine (DA), and Serotonin (5-HT) in 
P21 Rats Treated on P7 with DSP-4 in Relation to Saline Con-
trols
 NA DA 5-HT
Cortical tissue −80.7 (4.2)* −13.3 (23.0) +4.5 (16.0)
Non-cortical tissue
 (excluding cerebellum) −73.9 (7.8)* −4.7 (37.1) +23.6 (25.6)
Standard errors are in parentheses. *significant difference from 0%
Figure 1—Log-survivor plots of sleep (A) and wake (B) bout du-
rations in P21 rats treated with DSP-4 or saline. Each semi-log 
plot was constructed using pooled data (677-1180 data points). 
Straight lines on these plots indicate that the data follow an expo-
nential distribution.
Figure 2—Values of r2 using regression analysis of sleep (A) and 
wake (B) bout durations in DSP-4 and saline control P21 subjects. 
Sleep bout durations are better fit by exponential distributions 
during the day and night in subjects treated with DSP-4 or saline. 
Wake bout durations are better fit by power-law distributions in 
saline control subjects during the day and night. In contrast, wake 
bout durations in DSP-4 subjects are fit better by neither a power-
law nor exponential distribution during the day, but are better fit 
by an exponential distribution at night. *significant difference be-
tween exponential and power-law fits.
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and these effects persist into adulthood.19 Thus, we chose to in-
ject rats with DSP-4 at P7 and test them 2 weeks later with the 
expectation that NA would be depleted in any brain region to 
which the LC projects. In other words, NA concentration was 
used as a bioassay of the efficacy of the DSP-4 treatment. Our 
findings that DA and 5-HT concentrations were unaffected by 
DSP-4 treatment support previous findings that DSP-4 selec-
tively reduces NA concentration in the brain.19
The expression of sleep and wakefulness throughout the day 
and night reflect the variable influences of circadian and ho-
meostatic mechanisms.39 However, sleep and wake durations 
accumulate one bout at a time, and we now know that these 
individual bouts follow discernible statistical rules.4,6-8 These 
rules, in turn, reflect the dynamic interactions among hypotha-
lamic and brainstem nuclei involved in the expression of ultra-
dian sleep-wake cycles.
Wake bouts follow a power-law distribution in humans, cats, 
and rats,7,8,40 and wild-type and orexin knockout mice.3,7,36 This 
power-law structure (in which a small percentage wake bouts is 
considerably longer than most other wake bouts) may contrib-
ute to the efficient partitioning and budgeting of wake-related 
activities. Specifically, this power-law property may reflect the 
value for an animal of continuous and lengthy periods of wake-
fulness.
Among mathematical biologists, the significance of power-
law distributions and the mechanisms that give rise to them are 
topics of vigorous discussion.41,42 In the present context, it is 
worth considering that a power-law distribution is the signature 
of so-called scale-free networks comprising centralized hubs 
from which a disproportionate number of connections to other 
nodes in the network is made.43 In this regard, the neural sys-
tem that produces wakefulness may be viewed as a complex 
network comprising a collection of hubs with varying degrees 
of connectivity.41,44 Interestingly, LC neurons differentiate very 
early in development45 and soon give rise to a complex network 
of dense connections that project widely throughout the central 
nervous system, including the cerebral cortex, hippocampus, 
thalamus, midbrain, brainstem, cerebellum, and spinal cord.46-49 
The LC also receives dense projections from glutamatergic, 
GABAergic, orexinergic, serotonergic, and noradrenergic neu-
rons, among others.47 Accordingly, the LC, with its dense ef-
ferent and afferent projections, qualifies as a highly connected 
hub.
An interesting property of scale-free networks is that they 
are more robust (i.e., more resistant to failure) than are random 
networks50 in the face of random damage to the network. On the 
other hand, scale-free networks are more vulnerable to failure 
when damage comes in the form of an attack targeted at a hub. 
Thus, we hypothesize that the neural circuitry underlying the 
power-law structure of wake bouts has evolved in part because 
of its enhanced robustness in the face of random attack and that 
the use here of DSP-4 can be considered a “targeted” (i.e., non-
random) attack on the LC. If so, then it follows that the sleep 
system may be more sensitive than the wake system to ran-
dom neuronal loss (e.g., as appears to occur during aging51,52), 
perhaps providing an explanation for the relative prevalence of 
sleep-related disorders such as insomnia.53 We caution, how-
ever, that the convincing application of network theory to sleep-
wake organization will depend in part on the development of a 
discussion
The locus coeruleus is a major source of noradrenaline in the 
central nervous system that mediates spontaneous and evoked 
arousals.12,15 Here we used the neurotoxin DSP-4 to destroy NA 
terminals from the LC in order to assess the contributions of 
this structure to sleep and wake bout durations in P21 rats. We 
found no significant effect of DSP-4 on sleep bout durations, 
but wake bout durations were significantly increased, as was 
the percentage of time awake.
As expected, sleep bout durations uniformly followed ex-
ponential distributions that were unaffected by treatment with 
DSP-4. In contrast, whereas wake bout durations in saline con-
trol subjects were better fit by a power-law distribution, wake 
bout durations of DSP-4 subjects were better fit by an exponen-
tial distribution, as is the case in untreated younger rats.4,8 These 
conclusions were supported using 2 analytic procedures: least-
squares (r2) and maximum likelihood estimation.26,28,29 Thus, it 
appears that developmental changes in LC function contribute 
to the development of power-law wake behavior during the 
third postnatal week.
Previous studies have examined the role of DSP-4 on sleep 
and wakefulness in adults using conventional measures (e.g., 
mean, median, total sleep and wake durations); these studies 
have yielded variable and inconsistent results.20,30-33 In these 
studies, sleep and wake bout distributions were not analyzed, 
thus making it difficult to make direct comparisons between 
the results found in these earlier studies and those found here. 
Importantly, the current study is unique in that DSP-4 was in-
jected in early infancy—in particular, before the development 
of power-law wake behavior. Thus, the timing of DSP-4 ad-
ministration may critically determine its effects on wake bout 
distributions. It is also possible that analyses of sleep and wake 
bout distributions, rather than mere assessments of cumulative 
sleep and wake durations, provide a more reliable and sensitive 
indicator of sleep-wake dynamics and their underlying neural 
control.8,34
It has been suggested that arousal is maintained, at least in 
part, by an SCN-DMH-LC wake-active circuit.35 Orexinergic 
neurons within the DMH have been hypothesized to be critical-
ly involved in the maintenance of arousal35 and provide dense 
projections to the LC.11 However, power-law wake behavior de-
velops normally in orexin knockout mice3 and is expressed in 
adult mice.36 Thus, to the extent that the SCN-DMH-LC circuit 
is critically involved in arousal, it is possible that non-orexiner-
gic afferents to the LC, possibly from the DMH or elsewhere,35 
contribute to the development of power-law wake behavior in 
infant rats and mice. In addition, because the LC exerts inhibi-
tory influences on the sleep-promoting ventrolateral preoptic 
area (VLPO),37 it is possible that DSP-4 diminished this in-
hibitory influence, thereby altering the reciprocal interactions 
among LC, VLPO, and other nuclei involved in the regulation 
of sleep and wakefulness.38
The effects of DSP-4 treatment on NA in specific brain areas 
depend upon the age at which DSP-4 is administered and the 
interval between DSP-4 administration and NA measurement.19 
Using similar methods to those used here, DSP-4 treatment (50 
mg/kg) in week-old rats selectively and rapidly (i.e., within 1 
day) depletes NA in cerebral cortex, brainstem, and spinal cord, 
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neurotoxin DSP4 on the postnatal development of central nora-
drenaline neurons in the rat. Neuroscience 1982;7:2895-907.
20. Cirelli C, Huber R, Gopalakrishnan A, Southard TL, Tononi G. 
Locus ceruleus control of slow-wave homeostasis. J Neurosci 
2005;25:4503-11.
21. Cirelli C, Tononi G. Locus ceruleus control of state-dependent 
gene expression. J Neurosci 2004;24:5410-9.
22. Fritschy JM, Grzanna R. Immunohistochemical analysis of the 
neurotoxic effects of DSP-4 identifies two populations of nora-
drenergic axon terminals. Neuroscience 1989;30:181-97.
23. Fritschy JM, Grzanna R. Restoration of ascending noradrenergic 
projections by residual locus coeruleus neurons: compensatory 
response to neurotoxin-induced cell death in the adult rat brain. J 
Comp Neurol 1992;321:421-41.
24. Seelke AM, Karlsson KA, Gall AJ, Blumberg MS. Extraocular 
muscle activity, rapid eye movements and the development of ac-
tive and quiet sleep. Eur J Neurosci 2005;22:911-20.
25. Seelke AM, Blumberg MS. The microstructure of active and 
quiet sleep as cortical delta activity emerges in infant rats. Sleep 
2008;31:691-9.
26. Burnham KP, Anderson DR. Model selection and multimodel 
interference: a practical information-theoretic approach. 2nd ed. 
New York: Springer-Verlag, 2002.
27. Clauset A, Shalizi CR, Newman MEJ. Power-law distributions in 
empirical data. arXiv 2007;0706:1062.
28. Myung IJ. Tutorial on maximum likelihood estimation. J Math 
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30. Gonzalez MM, Aston-Jones G. Circadian regulation of arousal: 
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sure. Sleep 2006;29:1327-36.
31. Gonzalez MM, Debilly G, Valatx JL. Noradrenaline neurotoxin 
DSP-4 effects on sleep and brain temperature in the rat. Neurosci 
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DSP-4, a noradrenergic neurotoxin, on sleep and wakefulness and 
sensitivity to drugs acting on adrenergic receptors in the rat. Sleep 
1988;11:370-7.
33. Saponjic J, Radulovacki M, Carley DW. Monoaminergic system 
lesions increase post-sigh respiratory pattern disturbance during 
sleep in rats. Physiol Behav 2007;90:1-10.
process model of network behavior that can produce phenom-
ena akin to sleep and wake bouts.41
The present results highlight how a structure like the LC ex-
erts a subtle and complex influence that can be overlooked if 
sufficiently sensitive measures of sleep-wake cyclicity are not 
used. Thus, while we agree that the LC is likely more than sim-
ply a wake-active nucleus that modulates arousal,54 even our un-
derstanding of the role of the LC in the regulation of arousal is 
incomplete. We suggest that the LC comprises one component 
of a system that serves to modify the temporal structure of wake 
bouts such that prolonged periods of spontaneous wakefulness 
are possible. Given that this modification occurs in rats at the 
beginning of the third postnatal week, the LC and its associated 
structures may make it possible for the developing infant to en-
gage more effectively with its environment at a time of increas-
ing independence from its mother and littermates.
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